These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 17711303)
1. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Li JG; Chen C; Liu-Chen LY Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Li J; Li JG; Chen C; Zhang F; Liu-Chen LY Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. Li JG; Zhang F; Jin XL; Liu-Chen LY J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694 [TBL] [Abstract][Full Text] [Related]
4. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor. Chen C; Li JG; Chen Y; Huang P; Wang Y; Liu-Chen LY J Biol Chem; 2006 Mar; 281(12):7983-93. PubMed ID: 16431922 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation. Li JG; Benovic JL; Liu-Chen LY Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950 [TBL] [Abstract][Full Text] [Related]
6. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation. Zhang F; Li J; Li JG; Liu-Chen LY J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679 [TBL] [Abstract][Full Text] [Related]
7. Localization of the kappa opioid receptor in lipid rafts. Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160 [TBL] [Abstract][Full Text] [Related]
8. Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. Chen Y; Chen C; Wang Y; Liu-Chen LY J Pharmacol Exp Ther; 2006 Nov; 319(2):765-75. PubMed ID: 16882876 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation. Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376 [TBL] [Abstract][Full Text] [Related]
10. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation. Li JG; Haines DS; Liu-Chen LY Mol Pharmacol; 2008 Apr; 73(4):1319-30. PubMed ID: 18212250 [TBL] [Abstract][Full Text] [Related]
11. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991 [TBL] [Abstract][Full Text] [Related]
12. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. Li JG; Chen C; Liu-Chen LY J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055 [TBL] [Abstract][Full Text] [Related]
13. Agonist-induced regulation and trafficking of kappa opioid receptors. Liu-Chen LY Life Sci; 2004 Jun; 75(5):511-36. PubMed ID: 15158363 [TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor. Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. Compton SJ; Sandhu S; Wijesuriya SJ; Hollenberg MD Biochem J; 2002 Dec; 368(Pt 2):495-505. PubMed ID: 12171601 [TBL] [Abstract][Full Text] [Related]
16. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. Wang J; Shen F; Yan W; Wu M; Ratnam M Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177 [TBL] [Abstract][Full Text] [Related]
17. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells. Becker S; Klenk HD; Mühlberger E Virology; 1996 Nov; 225(1):145-55. PubMed ID: 8918541 [TBL] [Abstract][Full Text] [Related]